TABLE 4.
Control | CD | |
---|---|---|
Plasma homocysteine (μm) | 13.6 ± 1.6 | 75.9 ± 26.1a |
Body weight (g) | 21.0 ± 0.4 | 21.3 ± 1.0 |
Change in body weight (%) | +1.6 ± 1.6 | +2.6 ± 4.4 |
Plasma ALT (IU/L) | 35 ± 7 | 33 ± 5 |
Plasma glucose (mg/dL) | 143 ± 32 | 175 ± 22 |
Liver weight (g) | 1.00 ± 0.09 | 1.00 ± 0.03 |
Liver wt/body wt (%) | 4.4 ± 0.2 | 4.7 ± 0.2 |
Hepatic triglyceride (mg/mg protein) | 0.22 ± 0.06 | 0.36 ± 0.10a |
Hepatic SAM (nmol/g liver) | 66.8 ± 13.0 | 55.3 ± 9.0 |
Hepatic SAH (nmol/g liver) | 55.3 ± 14.8 | 71.8 ± 15.6 |
SAM/SAH ratio | 1.3 ± 0.4 | 0.8 ± 0.3 |
Relative mRNA levels | ||
BiP | 1.3 ± 1.0 | 1.7 ± 0.8 |
XBP-1(s) | 1.4 ± 1.3 | 1.4 ± 0.8 |
a p < 0.05 versus Control.